2012) package in R, which records the recurrence‐free survival time (in days) for 686 patients (with 299 events), all of whom had complete data for key standard factors such as age, tumor size, number of positive lymph nodes, progesterone and estrogen receptor status, menopausal status, and tumor grade. The gene discussed is ESR1; the disease is neoplasm.